The Epidermal Growth Factor Receptor (EGFR / HER-1) Gatekeeper Mutation T790M Is Present in European Patients with Early Breast Cancer

• Vahid Bemanian,

  Affiliations Department of Gene Technology, Akershus University Hospital, Lørenskog, Norway, University of Oslo, Institute of Clinical Medicine, Campus at Akershus University Hospital, Lørenskog, Norway

  ⨯
• Torill Sauer,

  Affiliations University of Oslo, Institute of Clinical Medicine, Campus at Akershus University Hospital, Lørenskog, Norway, Department of Pathology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Joel Touma,

  Affiliation Department of Breast- and Endocrine Surgery, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Bjørn Arne Lindstedt,

  Affiliations Department of Gene Technology, Akershus University Hospital, Lørenskog, Norway, University of Oslo, Institute of Clinical Medicine, Campus at Akershus University Hospital, Lørenskog, Norway

  ⨯
• Ying Chen,

  Affiliation Department of Pathology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Hilde Presterud Ødegård,

  Affiliation Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Katja Marjaana Vetvik,

  Affiliation Department of Breast- and Endocrine Surgery, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Ida Rashida Bukholm,

  Affiliations University of Oslo, Institute of Clinical Medicine, Campus at Akershus University Hospital, Lørenskog, Norway, Department of Breast- and Endocrine Surgery, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Jürgen Geisler

  * E-mail: juergen.geisler@medisin.uio.no

  Affiliations University of Oslo, Institute of Clinical Medicine, Campus at Akershus University Hospital, Lørenskog, Norway, Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯